A 72-year-old obese man with chronic atrial fibrillation, hypertension, hyperlipidemia, and a history of tobacco use presented for a routine office visit.
Two cardiovascular trials were conducted to evaluate the dipeptidyl peptidase-4 inhibitor sitagliptin and the glucagon-like peptide-1 receptor agonist lixisenatide.
It is with great pleasure that I invite you to read this special issue on cardiometabolic risk—which includes obesity, diabetes, dyslipidemia, and hypertension. This disease state affects more than 1 in 3...
A 64-year-old female presented for evaluation of a rash on her lower back of several months’ duration that was asymptomatic. She has had long-standing low back pain.
Although traditional insulins provide many options for treating patients with diabetes, some individuals require very high daily doses involving multiple shots that may cause local skin discomfort and...
A 12-year-old female comes to your office complaining of left ankle pain. Her mother states that she was at the playground when she jumped down from the high bars and has been in pain ever since.
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Last month we reviewed the case of CD, a 63-year-old white female who was diagnosed with chronic obstructive pulmonary disease (COPD) and initiated on tiotropium.
Two Top Papers have identified a medication that is both safe and effective in potassium removal. Patiromer is a high capacity, oral, nonabsorbed polymer that binds potassium in exchange for calcium in the...
“Type 2 diabetes is a manmade problem. We can prevent it,” said Tim Church, MD, as he kicked off the 2015 Cardiometabolic Risk Summit held in Las Vegas last month.